University of Vermont Began Pancreatic Cancer Trial
The clinical trial evaluates a new drug-delivery technology for patients with borderline pancreatic cancer.
Live Poll
Should cancer research prioritize developing targeted drug delivery systems over traditional systemic chemotherapy?